Lv1
12 积分 2025-09-25 加入
Efficacy and safety of twice per year depemokimab in chronic rhinosinusitis with nasal polyps (ANCHOR-1 and ANCHOR-2): phase 3, randomised, double-blind, parallel trials
2个月前
已完结
Precision Immunotherapy to Improve Sepsis Outcomes
3个月前
已完结
Precision Immunotherapy to Improve Sepsis Outcomes
3个月前
已完结
Precision Immunotherapy to Improve Sepsis Outcomes
3个月前
已完结
A Phase 3 Trial of Telitacicept for Systemic Lupus Erythematosus
3个月前
已完结
Impact of PD-L1 on first-line osimertinib outcomes in EGFR-mutant NSCLC: real-world data from the AURORA25 study and meta-analysis
5个月前
已完结
Efficacy and safety of Syk/VEGFR-2 Dual-target Kinase Inhibitor (OT202) in Dry Eye: A Randomized, Vehicle-controlled, Phase 2 Trial
6个月前
已完结
Efficacy and safety of dotinurad versus febuxostat for the treatment of gout: a randomised, multicentre, double‐blind, phase 3 trial in China
6个月前
已完结
Fifty years devoted to anaerobes: historical, lessons, and highlights
7个月前
已完结
Empirical antibiotic therapy for sepsis: save the anaerobic microbiota
7个月前
已完结
皖公网安备34019202002308
